MARKET

NVO

NVO

Novo Nordisk
NYSE

Real-time Quotes | Nasdaq Last Sale

54.51
+0.47
+0.87%
Opening 14:40 11/22 EST
OPEN
54.97
PREV CLOSE
54.04
HIGH
54.99
LOW
54.29
VOLUME
1.21M
TURNOVER
--
52 WEEK HIGH
58.01
52 WEEK LOW
43.60
MARKET CAP
127.75B
P/E (TTM)
22.97
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NVO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NVO News

  • Why Eli Lilly Can't Match Novo Nordisk
  • Seeking Alpha - Article.16h ago
  • Novo Nordisk Continues NASH Pipeline Push With Latest Product Bolt On
  • Seeking Alpha - Article.1d ago
  • Sanofi's Positive Diabetes Study Offers A New Treatment Alternative For Patients
  • Seeking Alpha - Article.1d ago
  • Launch of new generic drugs in U.S. still lags - WSJ
  • Seeking Alpha - Article.2d ago

More

Industry

Pharmaceuticals
+0.54%
Pharmaceuticals & Medical Research
+0.79%

Hot Stocks

Name
Price
%Change

About NVO

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
More

Webull offers Novo Nordisk A/S (ADR) (NVO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.